least four H-2D-encoded gene products: D, L, M, and R (15) (16) (17) (18) . In view of this complexity, it is important to first identify which antigens function as restriction molecules before evaluating the biological significance of viral/H-2 antigen membrane associations. For this reason, we have performed experiments designed to identify which H-2 molecules function as restriction antigens for anti-VSV CTL. The results of our studies are the subject of this report.
Materials and Methods
Mice. Mice were obtained from our animal colony at the University of Texas Health Science Center. The H-2 haplotype of the strains used are listed in Table I .
Virus. VSV of the Indiana serotype (VSV IND) was prepared by passage of the virus stock in the rat cell line R(B77). The source and culture conditions of R(B77) have been previously described (19) . VSV was titered by a plaque assay using R(B77) monolayers (19) .
Cells. P815 tumor cells (a DBA/2 mastocytoma) were maintained by biweekly passage in vitro in RPMI 1640 medium supplemented with 10% fetal calf serum and antibiotics. Alloreactive cytotoxic cells were induced following previously published procedures (20) . Spleen cells obtained from mice immunized 1-2 mo previously with 10 s plaque-forming units (PFU) of VSV were restimulated in vitro with VSV-infected stimulator cells to generate secondary anti-VSV CTL. The procedure has been described in detail elsewhere (8) . Secondary anti-VSV CTL were used in all experiments described in the report.
Assay for CTL Activity. CTL activity was measured using a standard chromium release assay (20) . Concanavalin A (Con A) -stimulated lymphoblast targets were radiolabeled with 51Cr and left uninfected or infected with VSV as previously described (8) . Various numbers of normal or immune lymphocytes were added to a constant number (104) of target cells in microtiter plates. After 4 h of incubation at 37°C, the cells were pelleted by centrifugation and the supernatant measured for radioactivity. Cold target competition analysis was performed following previously published procedures (21) using a constant number of effector cells (usually 106) and target cells (104 ) and various numbers of inhibitor cells. When various antisera or hybridoma products were tested for their ability to inhibit CTL activity, labeled targets were incubated with the indicated quantities of antibodies for 45 rain at 4°C. The effector cells were then added, and the mixtures were incubated and processed as described for the CTL assay. Antisera and Monoclonal Antibodies. Mice were given multiple injections of 3 × 10 v spleen cells approximately every 2 wk. Blood samples were obtained from the retro-orbital sinus and tested for cytotoxic activity. Only sera that contained high cytotoxic titers (>1/2,000) and could specifically immunopreeipitate H-2 antigens from cell-free lysates were used in these studies. Hybridomas specific for various H-2 antigens were kindly provided by Dr. Ted Hansen (Merck Institute for Therapeutic Research). The preparation and characterization of these reagents has been previously described (22) . Two monoclonal antibodies have anti-H-2.65 specificity (an H-2L a determinant); 23-10-1 is an IgM antibody and 30-5-7 is an IgG2a antibody. A third monoclonal antibody, 34-2-12, has anti-H-2.4 specificity (this antibody reacts with H-2D a but not H-2L d or H2Rd; K. Ozato, S. Epstein, J. A. Bluestone, S. O. Sharrow, T. Hanson, and D. H. Sachs, manuscript in preparation) and is an IgG2a antibody. Antisera and monoclones are listed in Table II . H-2D a. The fact that H-2 a'~a expresses H-2M a suggests that this molecule is also not involved in VSV recognition, although it cannot be ruled out that H-2M was affected by mutation. H-2 am1 expresses a mutant form of H-2D and H-2L, expresses H-2R (T. Hansen, personal communication), although it is not known whether this molecule has undergone mutation, and lacks H-2M. Taken together, these data demonstrate that H-2D a is not the H-2D regionrestricting locus and suggests that H-2L a may serve in this function.
TABLE I

H-2 Genotypes of Strains Used
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Results
Failure of Anti-VSV CTL to
Recognition of VSV is Restricted by the H-2L a Molecule.
Because the previous data suggest that H-2L d rather than H-2D d is involved in associative recognition of VSV (see Fig. 3 ), we directly evaluated the role of H-2L d as a restricting antigen. Two possibilities can be envisioned: either the H-2L molecule influences the orientation or conformation of H-2D, which facilitates an immunogenic interaction with VSV, or the anti-VSV T cell receptor is restricted by H-2L. To discriminate between these possibilities, anti-H-2 sera and monoclonal anti-H-2 antibodies were tested for their ability to block the cytotoxic activity of anti-VSV CTL in the CTL assay. activity in a dose-dependent fashion (Fig. 4) . The ability of the B10.D2(R103) anti-B10.D2 (anti-D region) serum to block anti-VSV activity against P815-VSV targets is consistent with the view that VSV is not H-2K-end restricted. That this inhibition was due to antibody binding to the H-2L molecule and not to H-2D can be seen by the ability of hybridomas specific for H-2L a (H-2.65) to block CTL activity. This is particularly true for the 30-5-7 (IgG2a) monoclone, which was very inhibitory even at low concentrations. On the other hand, a hybridoma specific for H-2D a (34-2-12), but not other H-2D-end-encoded molecules, had no inhibitory activity. Thus, these data clearly demonstrate that in the H-2 a haplotype, VSV is restricted solely by H-2L.
Antisera prepared against the whole H-2 d complex (B10.BR anti-B10.D2) or antigens encoded by the D-end of H-2 a (R103 anti-B10.D2) blocked anti-VSV CTL
To verify the specificity of these reagents, alloreactive CTL specific for either H-2K d, -D a, or -L d molecules were generated and various quantities of antibody were then tested for their ability to block CTL activity against particular H-2 molecules.
Ho2L-RESTRICTED ANTIVIRAL CYTOTOXIC T LYMPHOCYTES
The data in Fig. 5 illustrate that R103 anti-B10.D2 (anti-Dd-region) serum is D-end specific. For example, this serum blocked the lytic activity of H-2D-region-specific alloreactive CTL (R103 anti-BALB/c) (panel A), whereas it had no effect on the lytic activity of B10.D2(R107) (abbreviated R107) anti-BALB/c CTL (anti-H-2K-end) (panel B). As a control, we demonstrated that an antiserum (B10.BR anti-B10.D2) directed against antigens from the entire anti-H-2 a haplotype blocks both anti-H-2K-end and anti-H-2D region CTL responses (panels A and B). A hybridoma specific for the H-2L a molecule (30-5-7) inhibited the activity of H-2 am2 anti-BALB/c CTL (anti-H-2L a) (panel C), but this antibody, as well as monoclone 23-10-1 (anti-H-2Ld), was not inhibitory for R103 anti-H-2 am2 effector cells (panel D). It should be noted that H-2 a~ anti-BALB/c effector cells could potentially display lytic activity against H-2R, as H-2 ar~ animals lack this molecule. However, all the CTL activity was blocked with the anti-H-2L a monoclone (anti-2.65) (panel C and data from two other experiments [not shown] where the net isotope release at effector/target (E/T) ratio = 100 was 64.9 and 20.9). Therefore, these data indicate that H-2R is not recognized by H-2 ar~ anti-BALB/c alloreactive T cells. Finally, an H-2Da-specific hybridoma (34-2-12) caused no inhibition of the anti-H-2L d CTL reaction (panel C), whereas anti-H-2D a CTL activity was inhibited in a dose-dependent fashion (panel D). Thus, these antisera and hybridomas are functionally specific for individual H-2 molecules.
In summary, because monoclones 23-10-1 and 30-5-7 are specific for H-2L a and do not react against H-2R a, and H-2 a~ mice express H-2D a and H-2M a but their cells do not block CTL activity, these data indicate that H-2L, rather than H-2D, H-2M, or H-2R, restricts anti-VSV recognition in H-2 a mice.
Discussion
Anti-viral CTL are thought to play an important role in preventing the spread of virus infection. This is presumably achieved by the destruction of virus-infected cells by CTL during the eclipse period, a period before the assembly of mature infectious virus particles. This implies that viral antigens appear on the plasma membrane before the release of virus progeny, a view which is substantiated by kinetic studies in many systems (7, 1:2) . With all viruses tested to date, H-2K-or H-2D-region compatibility between effector and target cells is required for recognition of viral antigens by anti-viral CTL (1) .
We have demonstrated that BALB/c (H-2 a) anti-VSV CTL are similarly restricted by these same loci; in this study, compatibility at H-2L a was required, whereas H-2Ka-restricted recognition could not be demonstrated. In addition, H-2Da-restricted recognition could not be detected by cold target competition analysis or blocking studies with an anti-H-2Dd-specific hybridoma. However, VSV recognition was completely inhibited by two H-2L a specific monoclones. Although two other H-2D-region-encoded gene products, designated H-2M and -R, have been recently identified in the H-2 a haplotype (17, 18) , these molecules do not serve as restricting loci for VSV recognition in this mouse strain. Thus, VSV-infected cells obtained from H-2 am1 mice that express H-2M but not H-2L (18) (26) and minor histocompatibility antigens (27) . However, studies by Blanden et al. (28) have indicated a possible role for the H-2L molecule in T cell recognition of viral antigens. These investigators reported that a strong H-2Da-restricted CTL response against ectromelia virus could be elicited in BALB/c but not H-2 °m mice. Similarly, H-2 aminfected macrophages could not elicit secondary, H-2Da-restricted anti-ectromelia killer cells from in vivo primed cells. However, H-2am2-infected targets were as susceptible to lytic attack by H-2Da-restricted anti-ectromelia CTL as BALB/c infected targets. These authors suggested that the H-2L d molecule was not necessary for H-2Da-restricted recognition of this virus by activated cytotoxic effector cells, but rather that H-2L played some role, perhaps in the orientation or conformation of the H-2D ° molecule, which facilitated the putative associations between H-2D d and viral antigens required for triggering CTL precursors.
Indirect evidence for H-2La-restricted recognition of viral antigens has been obtained using monoclonal antibodies specific for H-2Dk-encoded determinants (29) . These antibodies blocked H-2Dk-restricted anti-influenza CTL activity but not antiBebaru virus killer cells. One interpretation of these data is that another D-endencoded molecule, presumably H-2L k, serves as the restriction antigen for Bebaru virus. However, an alternative interpretation is that influenza and Bebaru virus have different restriction determinants on the H-2D k molecule. In the latter case, these determinants are sufficiently distant from the allodeterminants recognized by the monoclonal antibodies, so that no steric hinderance by anti-Bebaru T cells occurs. In support of this, Weyand et al. (30) have demonstrated with monoclonal antibodies that there are different target regions on H-2 molecules.
The first direct evidence for the involvement of H-2L gene products in virus recognition was reported by Biddison et al. (3 I) , who showed, using anti-H-2L d-and H-2Dd-specific hybridomas, that influenza virus elicits two T cell subsets that are restricted by either H-2L or H-2D. However, because no recombinant strains have been detected that separate H-2L a from H-2D a, it cannot be determined ifH-2L a can restrict recognition without a similar activity by H-2D a. For example, H-2L may contain only one exon that can encode a restricting region and that is duplicated in the H-2D gene. On the other hand, H-2D may contain an additional (nonduplicated) exon that can also restrict antigen recognition. This possibility would predict that whenever H-2L restriction is observed for a given antigen, I-I-2D restriction would also be found, but not vice-versa. However, the data in the present report demonstrate that mouse strains with the H-2 a haplotype use H-2L exclusively as the restricting locus for anti-VSV CTL. Thus, H-2L uses a unique determinant involved in H-2-restricted recognition of virus, further substantiating the role of this molecule as a major class I antigen. This is the first demonstration of the exclusive use by a mouse strain of the H-2L molecule only for H-2-restricted recognition, and thus supports the notion that H-2L plays a major role in restricting antigen specific recognition. Finally, the fact that an anti-H-2L d monoclone completely blocked an H-2 ~ anti-BALB/c CTL response indicates that H-2R, a molecule absent in H-2 't~ but not BALB/c, does not sensitize H-2 alloreactive CTL.
